WCM
REGN icon

Wunderlich Capital Managemnt’s Regeneron Pharmaceuticals REGN Stock Holding History

Wunderlich Capital Managemnt’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$3.96M Sell
3,764
-47
-1% -$45.6K 1.77% 20
2024
Q1 		$3.67M Sell
3,811
-272
-7% -$259K 1.65% 24
2023
Q4 		$3.59M Sell
4,083
-137
-3% -$113K 1.61% 24
2023
Q3 		$3.47M Sell
4,220
-36
-0.8% -$28.3K 1.71% 19
2023
Q2 		$3.06M Sell
4,256
-39
-0.9% -$30.1K 1.5% 30
2023
Q1 		$3.53M Sell
4,295
-52
-1% -$39.2K 1.84% 16
2022
Q4 		$3.14M Sell
4,347
-120
-3% -$88.5K 1.75% 20
2022
Q3 		$3.08M Buy
4,467
+53
+1% +$33.4K 1.97% 14
2022
Q2 		$2.61M Buy
4,414
+15
+0.3% +$9.75K 1.52% 22
2022
Q1 		$3.07M Sell
4,399
-39
-0.9% -$24.7K 1.45% 23
2021
Q4 		$2.8M Buy
4,438
+46
+1% +$28.3K 1.25% 38
2021
Q3 		$2.66M Buy
4,392
+1
+0% +$621 1.28% 35
2021
Q2 		$2.45M Sell
4,391
-8
-0.2% -$4.05K 1.24% 38
2021
Q1 		$2.08M Sell
4,399
-83
-2% -$40.4K 1.14% 48
2020
Q4 		$2.17M Buy
4,482
+24
+0.5% +$13K 1.2% 37
2020
Q3 		$2.5M Sell
4,458
-149
-3% -$90.3K 1.54% 21
2020
Q2 		$2.87M Sell
4,607
-192
-4% -$109K 2.02% 12
2020
Q1 		$2.34M Sell
4,799
-144
-3% -$59.4K 1.93% 12
2019
Q4 		$1.86M Buy
4,943
+21
+0.4% +$7.07K 1.17% 43
2019
Q3 		$1.36M Buy
4,922
+79
+2% +$23.4K 0.94% 62
2019
Q2 		$1.52M Buy
4,843
+219
+5% +$72.9K 1.01% 53
2019
Q1 		$1.9M Buy
4,624
+56
+1% +$23.1K 1.32% 27
2018
Q4 		$1.71M Sell
4,568
-11
-0.2% -$4.03K 1.31% 32
2018
Q3 		$1.85M Sell
4,579
-251
-5% -$95.5K 1.31% 32
2018
Q2 		$1.67M Buy
+4,830
New +$1.51M 1.16% 40

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wunderlich Capital Managemnt's REGN Position: Q2 2024 in Review

Wunderlich Capital Managemnt reduced its Regeneron Pharmaceuticals (REGN) stake by 1.2% in Q2 2024, selling an estimated $45.6K and leaving 3,764 shares worth $3.96M. The position accounts for 1.77% of the portfolio, ranked #20.

Wunderlich Capital Managemnt first reported a position in REGN in Q2 2018 and has held it in 25 quarters since. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2024.

  • Wunderlich Capital Managemnt held 3,764 shares of Regeneron Pharmaceuticals worth $3.96M as of Q2 2024.
  • Wunderlich Capital Managemnt sold 47 Regeneron Pharmaceuticals shares in Q2 2024, an estimated $45.6K.
  • Regeneron Pharmaceuticals made up 1.77% of Wunderlich Capital Managemnt's portfolio in Q2 2024, its #20 holding.
  • Wunderlich Capital Managemnt first reported a position in Regeneron Pharmaceuticals in Q2 2018 and has held it in 25 quarters since.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2024.

Based on Wunderlich Capital Managemnt's 13F filing for Q2 2024, filed 14 Aug 2024.